Amcad Biomed CorporationTPEX: 4188

BOD revoked non-compete prohibition on financial and accounting officer

· Issued by AmCad BioMed Corporation
Close
Today's Information

Provided by: AmCad BioMed Corporation
SEQ_NO 5 Date of announcement 2022/02/18 Time of announcement 15:56:47
Subject
 AmCad BOD revoked non-compete prohibition on
financial and accounting officer
Date of events 2022/02/18 To which item it meets paragraph 21
Statement
1.Date of the board of directors resolution:2022/02/18
2.Name and title of the managerial officer with
permission to engage in competitive conduct:
 Maureen Chang / financial and accounting officer
3.Items of competitive conduct in which the officer is
permitted to engage:
 as financial and accounting officer in Broadsound Corporation
4.Period of permission to engage in the competitive
conduct:
 During the period as the financial and accounting officer in AmCad
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 32 of the
Company Act):
 Approved by all the attended directors
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
 title of the managerial officer (if it is not the
operator of a mainland China enterprise, please enter
"N/A" below):N/A
7.Company name of the mainland China enterprise and the
officer's position in the enterprise:N/A
8.Address of the mainland China enterprise:N/A
9.Operations of the mainland China enterprise:N/A
10.Impact on the company's finance and business:N/A
11.If the managerial officer or director has invested in
 the mainland China enterprise, the monetary amount of the
 investment and the officer or director's shareholding ratio:N/A
12.Any other matters that need to be specified:None

Earlier from Amcad Biomed

All Amcad Biomed news releases